Sidekick is a digital therapeutics company that helps people prevent and manage chronic diseases.
Sidekick specializes in the creation of gamified digital therapeutic solutions and programs, transforming chronic and lifestyle disease management across multiple therapeutic areas, ranging from diabetes to ulcerative colitis and smoking cessation.
Sidekick was founded in icelandd in 2013 by Tryggvi Thorgeirsson and Saemundur Oddsson. The company is headquartered in Reykjavík, Iceland, with offices in Sweden, Spain, Germany and New York.
Sidekick has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis.
Sidekick's approach combines behavioral economics, gamification and artificial intelligence for an engaging experience that removes barriers to health behavior change and expands the possibilities of well-being.
Sidekick's platform has helped 40,000+ patients globally at this stage, with its products currently available in six languages.
Sidekick is backed by Wellington Partners, Novator Ventures, Asabys Partners, Frumtak Ventures, and others. The company raised $55M in a Series B round on May 04, 2022. This brings Sidekick's total funding to $85M to date.